Tongkat Ali Physta 12 Weeks: Postmenopausal MENQOL -33.9% + Cortisol -16% — A Botanical Option

Eurycoma longifolia (Tongkat Ali) Physta standardized extract improved Menopause-Specific Quality of Life (MENQOL) by 33.9% over 12 weeks in 40-55-year-old peri/postmenopausal women. A separate 4-week 63-person study showed cortisol -16%, tension -11%, anger -12%, and confusion -15%. A plant-based option for women who decline or cannot take HRT — though monitor for androgenic effects (acne, hirsutism) and avoid in PCOS / hormone-sensitive disease.

The Data

Menopause RCT (12 Weeks)

• n: 40-55-year-old peri/postmenopausal women
• Drug: Tongkat Ali Physta standardized extract
• Results:
  • MENQOL composite score -33.9%
  • Hot flashes + night sweats improvement
  • Mood + fatigue + physical wellbeing improvement
  • Partial sleep quality improvement
• Side effects: minimal, placebo-level

Stress RCT (4 Weeks, n=63)

• Participants: 32 men + 31 women, moderately stressed
• Results (vs placebo):
  • Cortisol -16% (saliva)
  • Tension -11%
  • Anger -12%
  • Confusion -15%

Exercise Training + Body Composition

• Exercise + Tongkat Ali → modest lean mass increase, modest fat decrease
• Effect stronger in untrained subjects

Mechanism

Eurycoma longifolia root quassinoids (eurycomanone, eurycomanol) are key actives. Physta is a standardized aqueous extract.

Hormonal Action

• Mild phytoandrogen: SHBG (sex hormone binding globulin) blockade → modest free testosterone increase
• Estrogen modulation: partial preservation of postmenopausal estrogen pool
• Adrenal + thyroid signal normalization

Anti-Stress

• HPA axis modulation → cortisol normalization (raise when needed, lower in chronic state)
• Parasympathetic tone recovery
• Chronic stress → adaptation (adaptogen class)

Antioxidant + Anti-Inflammatory

• ROS neutralization
• Modest IL-6, TNF-α reduction

Mood + Energy

• Partial dopamine/serotonin signal modulation
• Improvement in chronic fatigue + low motivation

”Tongkat Ali = Male Hormone” Perception vs Data

Marketing Perception

• “Male testosterone booster”
• “Male exercise supplement”

Clinical Data

• Physta standardized extract: women’s menopause RCT MENQOL -33.9%
• Women’s stress RCT: cortisol -16% + mood improvement
• Exercise training (men + women): lean mass increase
• Women’s clinical data accumulating

Effective in women, but androgenic effects require monitoring.

Androgen Effects + Monitoring

Possible Side Effects

• Acne (especially during hormonal flux)
• Hirsutism (rare but possible)
• Mood swings (androgen + dopamine)
• Sleep (evening dosing may stimulate)

Monitoring

• 3-6 month testosterone, DHEA-S, SHBG measurement
• Self-symptoms: acne, hirsutism, mood swings
• PCOS family history: pre-evaluate
• Hormone-sensitive cancer: absolutely contraindicated

Korean Market

In Korea:

• Physta: introduced by some supplement brands (gray zone between general supplement vs functional food)
• Generic Tongkat Ali extracts: diverse market
• Non-standardized products: efficacy uncertain

Selection guide:

• Prioritize Physta® or LJ100® standardization
• Verify eurycomanone content disclosure
• Aqueous extract (traditional) vs alcohol extract differences
• Standard daily dose: 200-400 mg

Clinical Application

• Indication: peri/postmenopausal women, chronic stress, exercise recovery, lean preservation
• Dose: Physta 200-400 mg daily (with food)
• Timing: morning or noon (evening dosing may stimulate sleep)
• Time to effect: 4 weeks first change, 12 weeks stable
• Side effects: monitor androgenic effects (acne, hirsutism, mood)
• Contraindications: pregnancy/lactation, hormone-sensitive cancer, active PCOS
• Interactions: antidepressants (dopamine effects), hormonal therapy
• Synergy stack: Tongkat Ali + vitamin D + magnesium + ashwagandha + exercise
• HRT alternative: option for HRT-contraindicated/declined postmenopausal women
• Long-term gap: 1+ year data limited, reassess every 6 months